logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 [see all tables in this series...]

Part (v) Percentage distribution of route of administration amongst all clients with opioids as primary drug

CountryInjectSmoke/inhaleEat/drinkSniffOthersBase (known status)Status unknown
Bulgaria78.118.40.10.03.47702
Czech Republic80.05.611.03.20.174530
Denmark12.012.872.03.10.01744157
Germany42.517.634.24.11.71684217750
Ireland44.350.45.40.00.0249736
Greece42.410.50.446.60.1218834
Spain(1)20.659.46.06.67.4161223773
France25.113.08.353.20.590382239
Italy61.025.10.710.82.326847249
Cyprus73.922.22.21.70.01800
Lithuania98.50.01.30.10.0445526
Luxembourg71.124.64.30.00.02320
Hungary53.517.818.59.50.716160
Malta75.716.50.86.50.65225
Netherlands(2)8.371.416.03.21.11687461
Austria44.43.517.134.70.21677232
Slovakia84.810.92.02.00.33959
Finland82.11.18.97.90.063018
Sweden47.210.140.81.40.63586
United Kingdom(3)39.343.911.01.04.8644727195
Total43.034.311.37.93.515301732222

Notes:

 Only countries where there are clients reported with opiates as primary drug are shown. 

 (1) Data refer to 2005. 

 (2) Data refer to outpatient treatment centres and low-threshold agencies. 

 (3) Data refer to collection period between 1.4.2005 and 31.3.2006. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Thursday, 17 July 2008